Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mariana Massarenti"'
Autor:
Mariana Massarenti, Carla Sidiley Roveri da Silva, Sara Soldera Modenez, Marcelo Fukuhara Kawata, Lecy Kawamura, Marcelo Alvarenga Calil
Publikováno v:
O Mundo da Saúde, Vol 33, Iss 1 (2009)
O objetivo deste estudo foi avaliar o impacto da quimioterapia nas atividades diárias do paciente submetido a sessões de quimioterapia no IBCC. Para tanto, foram avaliados de forma prospectiva por questionários aplicados quanto à doença primári
Externí odkaz:
https://doaj.org/article/310282c2330644ba879b13caa18d7d4c
Autor:
Jaqueline Sapelli, Jayr Schmidt Filho, Otávio Cesar Carvalho Guimarães Baiocchi, Philip Bachour, André Neder Ramires Abdo, Juliana Fagioli Bombonatti, Silvia Rosi Lóss, Mariana Massarenti Langhi
Publikováno v:
Vascular Surgery in Oncology ISBN: 9783030976866
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1faa9ad132b32da9fa67ad9ed1188e6
https://doi.org/10.1007/978-3-030-97687-3_11
https://doi.org/10.1007/978-3-030-97687-3_11
Autor:
Sara Soldera Modenez, Marcelo Calil, Marcelo Fukuhara Kawata, Carla Sidiley Roveri da Silva, Mariana Massarenti, Lecy Kawamura
Publikováno v:
O Mundo da Saúde. 33:31-34
The objective of this study was to evaluate the impact of chemotherapy in daily activities of patients submitted to sessions at IBCC.For doing this, a prospective study was done using questionnaires applied regarding primary disease, what transportat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9bebbee946e7f070a218d7ee42146a8a
https://doi.org/10.15343/0104-7809.200933.1.4
https://doi.org/10.15343/0104-7809.200933.1.4
Autor:
Edvan de Queiroz Crusoe, Marina Rossato, Manuella S.S. Almeida, Luiza Vieira, P. Cury, Vania Hungria, Mariana Massarenti, Fabiana Higashi, Ana Lucia Peres, Anna Carolina Castro, Ana Luiza Silva
Publikováno v:
Blood. 124:5764-5764
Introduction: Despite the increase in overall survival in patients with multiple myeloma (MM) over the last decade as a result of the use of new chemotherapeutic agents, the immunomodulators (thalidomide and lenalidomide) are associated with a higher
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27d6fa0a017dc6a44e0384a9801b32ae
https://doi.org/10.1182/blood.v124.21.5764.5764
https://doi.org/10.1182/blood.v124.21.5764.5764